JAMA Oncology

JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association (AMA) and launched in 2015, devoted to medical, radiation and surgical oncology and their subspecialties, with a 2025 Journal Impact Factor of 23.9《JAMA 肿瘤学》是（American Medical Association，AMA）出版、2015 年创刊的月度同行评审医学期刊，专注医学肿瘤学、放射肿瘤学与外科肿瘤学及其亚专业，2025 年影响因子为 23.9。

Scope

• It publishes influential original research, reviews and opinions that advance the science of oncology and improve the clinical care of patients with cancer该刊刊载有影响力的原创研究、综述与观点，推动肿瘤学科学进步并改善癌症患者的临床照护。^[1]
• Its coverage spans all aspects of medical, radiation and surgical oncology and their subspecialties其报道涵盖医学肿瘤学、放射肿瘤学与外科肿瘤学及其亚专业的各个方面。
• Content is published online every Thursday and then collected in a monthly print and online issue内容每周四在线发布，随后汇编为每月一期的印刷版与在线版。
• Article types include Original Investigation, Brief Report, Review, Viewpoint, Editorial, Comment and Reply文章类型包括原创研究、研究快报、综述、观点、社论、评论与回复。
• It is an international peer-reviewed journal that emphasizes originality, methodological rigor and clinical relevance该刊是国际同行评审期刊，强调原创性、方法学严谨性与临床相关性。
• It is the oncology specialty title of the JAMA Network and is committed to improving the care of patients with cancer该刊是（JAMA Network）的肿瘤学专科刊物，致力于改善癌症患者的照护。

History

• JAMA Oncology was announced in 2014 and debuted in early 2015 as the 11th journal in the JAMA Network《JAMA 肿瘤学》于 2014 年宣布创办，2015 年初面世，是（JAMA Network）的第 11 种期刊。
• It was the first new journal launched by the JAMA Network since 1999它是（JAMA Network）自 1999 年以来推出的首本新刊。
• The journal was created to extend the JAMA Network into cancer care and cancer research该刊的创办旨在将（JAMA Network）的覆盖面延伸至癌症照护与研究领域。
• Nora Disis, MD, an internationally renowned cancer vaccine investigator and clinician, was appointed its inaugural editor-in-chief国际知名的癌症疫苗研究者与临床医生 Nora Disis（医学博士）被任命为该刊首任主编。
• It has been published continuously since 2015 and passed its 10-year mark in 2025该刊自 2015 年起持续出版，并于 2025 年跨过第 10 个年头。
• Its 2025 Journal Impact Factor is 23.9, ranking 14th among 333 oncology journals indexed in SCIE其 2025 年影响因子为 23.9，在 SCIE 收录的 333 种肿瘤学期刊中位列第 14。

Editors

• The editor-in-chief is Nora Disis, MD, a professor at the University of Washington and a leading researcher in cancer immunology现任主编为 Nora Disis 医学博士，她是（University of Washington）教授，也是癌症免疫学领域的领军研究者。
• She also serves as a deputy editor of JAMA, linking the journal to the wider JAMA Network她同时担任（JAMA）的副编辑，使该刊与（JAMA Network）整体相衔接。
• Her research focuses on developing cancer vaccines and immune-based diagnostic tests她的研究聚焦于癌症疫苗开发与基于免疫的诊断检测。
• The journal follows the JAMA Network's rigorous peer review and editorial standards该刊遵循（JAMA Network）严谨的同行评审与编辑标准。
• Its deputy and associate editors are drawn from leading cancer centers and academic institutions其副编辑与助理编辑来自顶尖癌症中心与学术机构。
• Every research article undergoes external peer review before publication每篇研究文章在刊发前均须经过外部同行评审。